Back
Inland Real Estate Income Trust, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Sell
18
INRE
Inland Real Estate Income Trust, Inc.
Last Price:
$10.5000
Seasonality Move:
4.83%
Sell
43
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.25
Seasonality Move:
0.84%
Sell
18
Inland Real Estate Income Trust, Inc. (INRE)
is a Sell
Is Inland Real Estate Income Trust, Inc. a Buy, Sell or Hold?
-
The current Inland Real Estate Income Trust, Inc. [INRE] share price is $10.5000. The Score for INRE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
INRE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $398.82. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INRE Stock Price Chart
What is Inland Real Estate Income Trust, Inc.'s stock price today?
-
The Inland Real Estate Income Trust, Inc. share price today is $10.5000Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INRE is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $398.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
INRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 32.66 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.24 - 11.44) | Sell |
| Bollinger Bands (100): | (8.3293 - 13.4893) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.02 | Sell |
| Relative Strength Index (14 RSI): | 38.18 | Sell |
| Chaikin Money Flow: | -239813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (395.38 - 448.66) | Sell |
| Bollinger Bands (100): | (424.51 - 470.03) | Sell |
INRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.5 | Sell |
| 20-day SMA: | 10.65 | Sell |
| 50-day SMA: | 11.16 | Sell |
| 200-day SMA: | 11.2 | Sell |
| 8-day EMA: | 10.51 | Sell |
| 20-day EMA: | 10.67 | Sell |
| 50-day EMA: | 10.93 | Sell |
| 200-day EMA: | 11.05 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 399.36 | Sell |
| 20-day SMA: | 417.68 | Sell |
| 50-day SMA: | 439.71 | Sell |
| 200-day SMA: | 369.63 | Buy |
| 8-day EMA: | 401.33 | Sell |
| 20-day EMA: | 412.78 | Sell |
| 50-day EMA: | 428.62 | Sell |
| 200-day EMA: | 383.63 | Buy |
Inland Real Estate Income Trust, Inc. Earnings Growth & INRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and a decrease next year of $0.00 per share.
Inland Real Estate Income Trust, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||